Hematoporphyrin-Derivative Fluorescence in Malignant Neoplasms
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
The Use of a Derivative of Hematoporphyrin in Tumor Detection<xref ref-type="fn" rid="FN1">2</xref><xref ref-type="fn" rid="FN2">3</xref>
1961 • 634 citations
HEMATOPORPHYRIN DERIVATIVE: A NEW AID FOR ENDOSCOPIC DETECTION OF MALIGNANT DISEASE
1961 • 250 citations
Further Evaluation of the Use of Hematoporphyrin Derivative As a New Aid for the Endoscopic Detection of Malignant Disease* *From the Mayo Clinic and Mayo Foundation. This investigation was supported in part by Research Grant ASP-9880 from the National Institutes of Health, Public Health Service.
1964 • 80 citations
Attempts at tumor localization using CU64-labeled copper porphyrins
1958 • 61 citations
Mechanisms involved in the production of red fluorescence of human and experimental tumours
1963 • 47 citations
A New Phospholipid, Malignolipin, in Human Malignant Tumors
1958 • 44 citations
Tetracycline fluorescence in malignant tumors and benign ulcers.
1960 • 44 citations
Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration.
1960 • 39 citations
Porphyrin metabolism in human neoplastic tissues.
1966 • 35 citations
Localization of a Halogenated Porphyrin in Mouse Tumours
1960 • 19 citations
Porphyrin iii Staining of “Malignolipin” in Tumors
1960 • 6 citations
PRELIMINARY OBSERVATIONS IN A CLINICAL STUDY OF HEMATOPORPHYRIN-DERIVATIVE FLUORESCENCE IN MALIGNANT NEOPLASMS.
1964 • 6 citations